Skip to content

Effect of Customized Healing Abutments on Peri-implant Soft Tissue and Bone

Effect of Customized Healing Abutments on Peri-implant Soft Tissue and Bone

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06125418
Enrollment
60
Registered
2023-11-09
Start date
2022-06-01
Completion date
2025-12-20
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peri-implant Tissue Response With Use of Customized Healing Abutments

Keywords

dental implant, customized healing abutment

Brief summary

The goal of this clinical trial is to evaluate effect of customized healing abutment in patients who need single implant reconstruction. The main question it aims to answer is: • effect of customized healing abutment on peri-implant soft and hard tissue Participants will received customized healing abutments before final prostheses delivery.

Detailed description

Patients who need single implant restoration will be received one- stage implant placement with utilization of customized healing abutment. Data collection about change in hard and soft tissue will be collected digitally at several times points. Patients will received single crown on implant as final prosthesis. Change in peri-implant tissue will be analyzed with digital softwares.

Interventions

patients will undergoes one-stage implant placement with customized healing abutments with different macrogeometry and emergence angle made prior to the surgery and will be inserted without sutures, after osseointegration completed patients will received single crown on implant.

patients will undergoes one-stage implant placement with standard titanium healing abutment made prior to the surgery and will be inserted without sutures, after osseointegration completed patients will received single crown on implant.

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Intervention model description

patients in each group will received different types of customized healing abutment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥18 years of age; * patients who needed a single implant placing therapy in maxillary or mandibular arch except in third molar regions * sufficient mesial distal and interocclusal space for placement of the implant and definitive restoration; * had sufficient apical bone to place an implant with minimum primary stability of 30 Ncm.

Exclusion criteria

* medical and general contraindications for the surgical procedure; * heavy smokers (\>10 cigarettes/day); * an active infection at the implant site.

Design outcomes

Primary

MeasureTime frameDescription
soft tissue alterationT0 baseline before implant placement,T1 1month follow up, 4month follow up, 6month follow up, 12month follow upperi-implant soft tissue change compared to baseline including vertical and horizontal soft tissue alteration by superimposing intraoral scan at different time points
hard tissue alterationT0 baseline before implant placement, 6month follow up, 12month follow upperi-implant marginal bone change compared to baseline at different time points by periapical radiograph
volumetric alterationT0 baseline before implant placement,T1 1month follow up, 4month follow up, 6month follow up, 12month follow upperi-implant volumetric change at different time points compared to baseline with superimposing intraoral scan

Secondary

MeasureTime frameDescription
pain numerical rating scaleat prosthesis delivery, 2 hours and 24 hours after prosthesis deliverypain assessment at time of final prosthesis delivery with scale from 0 to 10
pink esthetic scoreT0 baseline before implant placement, 6 month follow uppink esthetic score change compared to before implant treatment

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026